Association of anemia with outcomes in men with moderate and severe chronic kidney disease

Anemia is a common complication of chronic kidney disease (CKD), but the outcomes associated with lower hemoglobin (Hgb) levels in patients with CKD not yet on dialysis are not well characterized. Analyses exploring outcomes associated with a single baseline Hgb value also do not account for the lon...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Kidney international 2006-02, Vol.69 (3), p.560-564
Hauptverfasser: Kovesdy, C.P., Trivedi, B.K., Kalantar-Zadeh, K., Anderson, J.E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 564
container_issue 3
container_start_page 560
container_title Kidney international
container_volume 69
creator Kovesdy, C.P.
Trivedi, B.K.
Kalantar-Zadeh, K.
Anderson, J.E.
description Anemia is a common complication of chronic kidney disease (CKD), but the outcomes associated with lower hemoglobin (Hgb) levels in patients with CKD not yet on dialysis are not well characterized. Analyses exploring outcomes associated with a single baseline Hgb value also do not account for the longitudinal variation of this measure. After collecting all Hgb measurements (N=17 194, median (range): 12 (1–168)) over a median follow-up period of 2.1 years in a historical prospective cohort of 853 male US veterans with CKD Stages 3–5 not yet on dialysis, we examined the association of time-averaged Hgb levels with predialysis all-cause mortality, end-stage renal disease (ESRD), and a composite end point of both. Kaplan–Meier survival analysis and Cox models adjusted for age, race, body mass index, smoking status, blood pressure, diabetes mellitus, cardiovascular disease, categories of estimated glomerular filtration rate, serum concentrations of albumin and cholesterol, and proteinuria were examined. Lower time-averaged Hgb was associated with significantly higher hazard of the composite end point (hazard ratio (95% confidence interval) in the adjusted model for time-averaged Hgb of 130 g/l: 2.57 (1.85–3.58), 1.97 (1.45–2.66), 1.19 (0.86–1.63), Ptrend
doi_str_mv 10.1038/sj.ki.5000105
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70716639</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0085253815515081</els_id><sourcerecordid>978748901</sourcerecordid><originalsourceid>FETCH-LOGICAL-c435t-2c328697d2012523563ef0901501efbe23a2bb772718f68c82458a7693e687783</originalsourceid><addsrcrecordid>eNp10MuLFDEQBvAgijuuHr1KEPTWYx6TRx-XxRcseNGLl5BJV7M1M52sqe6V_e-NTMOC4ClQ-VF89TH2WoqtFNp_oMP2iFsjhJDCPGEbaZTupDPmKdsI4U2njPYX7AXRoRnfa_GcXUire9M-NuznFVFJGGcsmZeRxwwTRv4b51teljmVCYhj5hPk83AqA9Q4Q5MDJ7iHCjzd1pIx8SMOGR74gASR4CV7NsYTwav1vWQ_Pn38fv2lu_n2-ev11U2XdtrMnUpaedu7QQmpWnhjNYyiF9IICeMelI5qv3dOOelH65NXO-Ojs70G653z-pK9P--9q-XXAjSHCSnB6dRuKQsFJ5y07eAG3_4DD2WpuWULSgophe1NQ90ZpVqIKozhruIU60OQIvxtPNAhHDGsjTf_Zl267CcYHvVacQPvVhApxdNYY05Ij871aieVbc6dHbSu7hFqoISQEwxYIc1hKPifCH8Au_uaUQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>210110695</pqid></control><display><type>article</type><title>Association of anemia with outcomes in men with moderate and severe chronic kidney disease</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Kovesdy, C.P. ; Trivedi, B.K. ; Kalantar-Zadeh, K. ; Anderson, J.E.</creator><creatorcontrib>Kovesdy, C.P. ; Trivedi, B.K. ; Kalantar-Zadeh, K. ; Anderson, J.E.</creatorcontrib><description>Anemia is a common complication of chronic kidney disease (CKD), but the outcomes associated with lower hemoglobin (Hgb) levels in patients with CKD not yet on dialysis are not well characterized. Analyses exploring outcomes associated with a single baseline Hgb value also do not account for the longitudinal variation of this measure. After collecting all Hgb measurements (N=17 194, median (range): 12 (1–168)) over a median follow-up period of 2.1 years in a historical prospective cohort of 853 male US veterans with CKD Stages 3–5 not yet on dialysis, we examined the association of time-averaged Hgb levels with predialysis all-cause mortality, end-stage renal disease (ESRD), and a composite end point of both. Kaplan–Meier survival analysis and Cox models adjusted for age, race, body mass index, smoking status, blood pressure, diabetes mellitus, cardiovascular disease, categories of estimated glomerular filtration rate, serum concentrations of albumin and cholesterol, and proteinuria were examined. Lower time-averaged Hgb was associated with significantly higher hazard of the composite end point (hazard ratio (95% confidence interval) in the adjusted model for time-averaged Hgb of &lt;110, 111–120 and 121–130, compared to &gt;130 g/l: 2.57 (1.85–3.58), 1.97 (1.45–2.66), 1.19 (0.86–1.63), Ptrend&lt;0.001). Lower time-averaged Hgb was associated with both significantly higher pre-dialysis mortality and higher risk of ESRD, when analyzed separately. Anemia (especially time-averaged Hgb &lt;120 g/l) is associated with both higher mortality and increased risk of ESRD in male patients with CKD not yet on dialysis.</description><identifier>ISSN: 0085-2538</identifier><identifier>EISSN: 1523-1755</identifier><identifier>DOI: 10.1038/sj.ki.5000105</identifier><identifier>PMID: 16395253</identifier><identifier>CODEN: KDYIA5</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Aged ; anemia ; Anemia - blood ; Anemia - complications ; Anemia - physiopathology ; Anemias. Hemoglobinopathies ; Biological and medical sciences ; Chronic Disease ; chronic kidney disease ; Cohort Studies ; Diseases of red blood cells ; end-stage renal disease ; Follow-Up Studies ; Hematologic and hematopoietic diseases ; Hemoglobins - analysis ; Humans ; Kidney Diseases - blood ; Kidney Diseases - complications ; Kidney Diseases - mortality ; Kidney Diseases - physiopathology ; Kidney Failure, Chronic - blood ; Kidney Failure, Chronic - epidemiology ; Kidney Failure, Chronic - etiology ; Kidney Failure, Chronic - physiopathology ; Kidneys ; Male ; Medical sciences ; Middle Aged ; mortality ; Nephrology. Urinary tract diseases ; Proportional Hazards Models ; Prospective Studies ; Risk Factors ; Severity of Illness Index ; Survival Analysis ; Urinary system involvement in other diseases. Miscellaneous</subject><ispartof>Kidney international, 2006-02, Vol.69 (3), p.560-564</ispartof><rights>2006 International Society of Nephrology</rights><rights>2006 INIST-CNRS</rights><rights>Copyright Nature Publishing Group Feb 2006</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c435t-2c328697d2012523563ef0901501efbe23a2bb772718f68c82458a7693e687783</citedby><cites>FETCH-LOGICAL-c435t-2c328697d2012523563ef0901501efbe23a2bb772718f68c82458a7693e687783</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17924126$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16395253$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kovesdy, C.P.</creatorcontrib><creatorcontrib>Trivedi, B.K.</creatorcontrib><creatorcontrib>Kalantar-Zadeh, K.</creatorcontrib><creatorcontrib>Anderson, J.E.</creatorcontrib><title>Association of anemia with outcomes in men with moderate and severe chronic kidney disease</title><title>Kidney international</title><addtitle>Kidney Int</addtitle><description>Anemia is a common complication of chronic kidney disease (CKD), but the outcomes associated with lower hemoglobin (Hgb) levels in patients with CKD not yet on dialysis are not well characterized. Analyses exploring outcomes associated with a single baseline Hgb value also do not account for the longitudinal variation of this measure. After collecting all Hgb measurements (N=17 194, median (range): 12 (1–168)) over a median follow-up period of 2.1 years in a historical prospective cohort of 853 male US veterans with CKD Stages 3–5 not yet on dialysis, we examined the association of time-averaged Hgb levels with predialysis all-cause mortality, end-stage renal disease (ESRD), and a composite end point of both. Kaplan–Meier survival analysis and Cox models adjusted for age, race, body mass index, smoking status, blood pressure, diabetes mellitus, cardiovascular disease, categories of estimated glomerular filtration rate, serum concentrations of albumin and cholesterol, and proteinuria were examined. Lower time-averaged Hgb was associated with significantly higher hazard of the composite end point (hazard ratio (95% confidence interval) in the adjusted model for time-averaged Hgb of &lt;110, 111–120 and 121–130, compared to &gt;130 g/l: 2.57 (1.85–3.58), 1.97 (1.45–2.66), 1.19 (0.86–1.63), Ptrend&lt;0.001). Lower time-averaged Hgb was associated with both significantly higher pre-dialysis mortality and higher risk of ESRD, when analyzed separately. Anemia (especially time-averaged Hgb &lt;120 g/l) is associated with both higher mortality and increased risk of ESRD in male patients with CKD not yet on dialysis.</description><subject>Aged</subject><subject>anemia</subject><subject>Anemia - blood</subject><subject>Anemia - complications</subject><subject>Anemia - physiopathology</subject><subject>Anemias. Hemoglobinopathies</subject><subject>Biological and medical sciences</subject><subject>Chronic Disease</subject><subject>chronic kidney disease</subject><subject>Cohort Studies</subject><subject>Diseases of red blood cells</subject><subject>end-stage renal disease</subject><subject>Follow-Up Studies</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Hemoglobins - analysis</subject><subject>Humans</subject><subject>Kidney Diseases - blood</subject><subject>Kidney Diseases - complications</subject><subject>Kidney Diseases - mortality</subject><subject>Kidney Diseases - physiopathology</subject><subject>Kidney Failure, Chronic - blood</subject><subject>Kidney Failure, Chronic - epidemiology</subject><subject>Kidney Failure, Chronic - etiology</subject><subject>Kidney Failure, Chronic - physiopathology</subject><subject>Kidneys</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>mortality</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Proportional Hazards Models</subject><subject>Prospective Studies</subject><subject>Risk Factors</subject><subject>Severity of Illness Index</subject><subject>Survival Analysis</subject><subject>Urinary system involvement in other diseases. Miscellaneous</subject><issn>0085-2538</issn><issn>1523-1755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp10MuLFDEQBvAgijuuHr1KEPTWYx6TRx-XxRcseNGLl5BJV7M1M52sqe6V_e-NTMOC4ClQ-VF89TH2WoqtFNp_oMP2iFsjhJDCPGEbaZTupDPmKdsI4U2njPYX7AXRoRnfa_GcXUire9M-NuznFVFJGGcsmZeRxwwTRv4b51teljmVCYhj5hPk83AqA9Q4Q5MDJ7iHCjzd1pIx8SMOGR74gASR4CV7NsYTwav1vWQ_Pn38fv2lu_n2-ev11U2XdtrMnUpaedu7QQmpWnhjNYyiF9IICeMelI5qv3dOOelH65NXO-Ojs70G653z-pK9P--9q-XXAjSHCSnB6dRuKQsFJ5y07eAG3_4DD2WpuWULSgophe1NQ90ZpVqIKozhruIU60OQIvxtPNAhHDGsjTf_Zl267CcYHvVacQPvVhApxdNYY05Ij871aieVbc6dHbSu7hFqoISQEwxYIc1hKPifCH8Au_uaUQ</recordid><startdate>20060201</startdate><enddate>20060201</enddate><creator>Kovesdy, C.P.</creator><creator>Trivedi, B.K.</creator><creator>Kalantar-Zadeh, K.</creator><creator>Anderson, J.E.</creator><general>Elsevier Inc</general><general>Nature Publishing</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20060201</creationdate><title>Association of anemia with outcomes in men with moderate and severe chronic kidney disease</title><author>Kovesdy, C.P. ; Trivedi, B.K. ; Kalantar-Zadeh, K. ; Anderson, J.E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c435t-2c328697d2012523563ef0901501efbe23a2bb772718f68c82458a7693e687783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Aged</topic><topic>anemia</topic><topic>Anemia - blood</topic><topic>Anemia - complications</topic><topic>Anemia - physiopathology</topic><topic>Anemias. Hemoglobinopathies</topic><topic>Biological and medical sciences</topic><topic>Chronic Disease</topic><topic>chronic kidney disease</topic><topic>Cohort Studies</topic><topic>Diseases of red blood cells</topic><topic>end-stage renal disease</topic><topic>Follow-Up Studies</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Hemoglobins - analysis</topic><topic>Humans</topic><topic>Kidney Diseases - blood</topic><topic>Kidney Diseases - complications</topic><topic>Kidney Diseases - mortality</topic><topic>Kidney Diseases - physiopathology</topic><topic>Kidney Failure, Chronic - blood</topic><topic>Kidney Failure, Chronic - epidemiology</topic><topic>Kidney Failure, Chronic - etiology</topic><topic>Kidney Failure, Chronic - physiopathology</topic><topic>Kidneys</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>mortality</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Proportional Hazards Models</topic><topic>Prospective Studies</topic><topic>Risk Factors</topic><topic>Severity of Illness Index</topic><topic>Survival Analysis</topic><topic>Urinary system involvement in other diseases. Miscellaneous</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kovesdy, C.P.</creatorcontrib><creatorcontrib>Trivedi, B.K.</creatorcontrib><creatorcontrib>Kalantar-Zadeh, K.</creatorcontrib><creatorcontrib>Anderson, J.E.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Kidney international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kovesdy, C.P.</au><au>Trivedi, B.K.</au><au>Kalantar-Zadeh, K.</au><au>Anderson, J.E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association of anemia with outcomes in men with moderate and severe chronic kidney disease</atitle><jtitle>Kidney international</jtitle><addtitle>Kidney Int</addtitle><date>2006-02-01</date><risdate>2006</risdate><volume>69</volume><issue>3</issue><spage>560</spage><epage>564</epage><pages>560-564</pages><issn>0085-2538</issn><eissn>1523-1755</eissn><coden>KDYIA5</coden><abstract>Anemia is a common complication of chronic kidney disease (CKD), but the outcomes associated with lower hemoglobin (Hgb) levels in patients with CKD not yet on dialysis are not well characterized. Analyses exploring outcomes associated with a single baseline Hgb value also do not account for the longitudinal variation of this measure. After collecting all Hgb measurements (N=17 194, median (range): 12 (1–168)) over a median follow-up period of 2.1 years in a historical prospective cohort of 853 male US veterans with CKD Stages 3–5 not yet on dialysis, we examined the association of time-averaged Hgb levels with predialysis all-cause mortality, end-stage renal disease (ESRD), and a composite end point of both. Kaplan–Meier survival analysis and Cox models adjusted for age, race, body mass index, smoking status, blood pressure, diabetes mellitus, cardiovascular disease, categories of estimated glomerular filtration rate, serum concentrations of albumin and cholesterol, and proteinuria were examined. Lower time-averaged Hgb was associated with significantly higher hazard of the composite end point (hazard ratio (95% confidence interval) in the adjusted model for time-averaged Hgb of &lt;110, 111–120 and 121–130, compared to &gt;130 g/l: 2.57 (1.85–3.58), 1.97 (1.45–2.66), 1.19 (0.86–1.63), Ptrend&lt;0.001). Lower time-averaged Hgb was associated with both significantly higher pre-dialysis mortality and higher risk of ESRD, when analyzed separately. Anemia (especially time-averaged Hgb &lt;120 g/l) is associated with both higher mortality and increased risk of ESRD in male patients with CKD not yet on dialysis.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>16395253</pmid><doi>10.1038/sj.ki.5000105</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0085-2538
ispartof Kidney international, 2006-02, Vol.69 (3), p.560-564
issn 0085-2538
1523-1755
language eng
recordid cdi_proquest_miscellaneous_70716639
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Aged
anemia
Anemia - blood
Anemia - complications
Anemia - physiopathology
Anemias. Hemoglobinopathies
Biological and medical sciences
Chronic Disease
chronic kidney disease
Cohort Studies
Diseases of red blood cells
end-stage renal disease
Follow-Up Studies
Hematologic and hematopoietic diseases
Hemoglobins - analysis
Humans
Kidney Diseases - blood
Kidney Diseases - complications
Kidney Diseases - mortality
Kidney Diseases - physiopathology
Kidney Failure, Chronic - blood
Kidney Failure, Chronic - epidemiology
Kidney Failure, Chronic - etiology
Kidney Failure, Chronic - physiopathology
Kidneys
Male
Medical sciences
Middle Aged
mortality
Nephrology. Urinary tract diseases
Proportional Hazards Models
Prospective Studies
Risk Factors
Severity of Illness Index
Survival Analysis
Urinary system involvement in other diseases. Miscellaneous
title Association of anemia with outcomes in men with moderate and severe chronic kidney disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T16%3A37%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20of%20anemia%20with%20outcomes%20in%20men%20with%20moderate%20and%20severe%20chronic%20kidney%20disease&rft.jtitle=Kidney%20international&rft.au=Kovesdy,%20C.P.&rft.date=2006-02-01&rft.volume=69&rft.issue=3&rft.spage=560&rft.epage=564&rft.pages=560-564&rft.issn=0085-2538&rft.eissn=1523-1755&rft.coden=KDYIA5&rft_id=info:doi/10.1038/sj.ki.5000105&rft_dat=%3Cproquest_cross%3E978748901%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=210110695&rft_id=info:pmid/16395253&rft_els_id=S0085253815515081&rfr_iscdi=true